Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sickle cell anaemia trial.

M H Gaston1, J Verter

  • 1National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892.

Statistics in Medicine
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) Trial.

American heart journal·2001
Same author

Inequality in America: the contribution of health centers in reducing and eliminating disparities in access to care.

Medical care research and review : MCRR·2001
Same author

Cancer screening among community health center women: eliminating the gaps.

The Journal of ambulatory care management·2001
Same author

Improving diabetes care in community health centers.

American journal of public health·2001
Same author

The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.

Pediatrics·2001
Same author

Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network.

Pediatrics·2001
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Prophylactic penicillin significantly reduces severe Streptococcus pneumoniae infections in young children with sickle cell anaemia. This oral treatment is a cost-effective strategy to prevent life-threatening infections and mortality in this vulnerable population.

Area of Science:

  • Pediatric Hematology
  • Infectious Diseases
  • Public Health

Background:

  • Sickle cell anaemia (SCA) significantly increases the risk of severe infections, primarily from Streptococcus pneumoniae.
  • Infection is the leading cause of mortality in SCA patients, particularly in children under three years old.
  • Untreated, approximately one-third of infants with SCA may die from infection within their first three years.

Purpose of the Study:

  • To evaluate the efficacy of oral prophylactic penicillin in preventing severe Streptococcus pneumoniae infections in infants with SCA.
  • To determine the cost-effectiveness of early penicillin prophylaxis in SCA management.

Main Methods:

  • Conducted the Prophylactic Penicillin Study (PROPS), a clinical trial within an existing study framework.

Related Experiment Videos

  • Utilized up-to-date incidence data for accurate sample size estimation and study design.
  • Focused on oral administration of prophylactic penicillin.

    • Main Results:

    • Oral prophylactic penicillin proved effective in preventing severe infections caused by Streptococcus pneumoniae.
    • The study demonstrated a significant reduction in infection-related morbidity and mortality.
    • The PROPS trial was efficient and cost-effective due to its timely execution and integrated design.

    Conclusions:

    • Oral prophylactic penicillin is a crucial, cost-effective intervention for preventing severe Streptococcus pneumoniae infections in children with sickle cell anaemia.
    • Early penicillin prophylaxis significantly improves survival rates in young SCA patients.
    • This strategy addresses a major cause of death in the SCA population.